락토페린 시장 보고서 : 기능, 용도, 지역별(2025-2033년)

The global lactoferrin market size reached USD 308.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 537.8 Million by 2033, exhibiting a growth rate (CAGR) of 6.05% during 2025-2033.

Lactoferrin is a multi-functional glycoprotein commonly found in human and bovine milk, saliva, tears, bile and mucus. It binds with iron ions present in the blood and transports it through the body. It is a rich source of antioxidants and aids in improving immunity and preventing bacterial and viral infections. It is also commercially sourced from genetically modified rice and is used as a protein supplement in pharmaceutical medicines to treat stomach and intestinal ulcers, diarrhea and hepatitis C. Lactoferrin also aids in preventing tissue damage and cancer, regulating iron metabolism and minimizing damage caused by aging. As a result, it finds extensive applications across various industries, including pharmaceuticals, food and beverages, nutraceuticals and personal care products.

The increasing prevalence of bacterial and viral infections across the globe represents one of the key factors driving the growth of the market. Lactoferrin accelerates bone and joints healing and prevents bone loss caused by various medical ailments. Furthermore, rising health consciousness among the masses, along with the increasing demand for lactoferrin-based nutritional supplements, is also driving the market growth. In line with this, lactoferrin is also widely used in the manufacturing of various cosmetics and personal care products due to its beneficial acne-treating, anti-allergic and anti-aging properties. It stimulates connective tissue and epidermal cells that aid in healing skin lesions. Additionally, various product innovations, such as the launch of infant formula fortified with lactoferrin, are acting as other growth-inducing factors. It is also used for the production of various sports nutrition products and functional supplements. Other factors, including the rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Function:

• Iron Absorption
• Anti-Inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant
• Others

Breakup by Application:

• Food and Beverages
• Infant Formula
• Sports and Functional Foods
• Pharmaceuticals
• Personal Care Products
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bega Cheese Limited, Farbest Brands, Ferrin-Tech LLC, Fonterra Cooperative Group Ltd., Glanbia PLC, Hoogwegt Group B.V., Ingredia SA, Metagenics Inc. (Alticor Inc.), MILEI GmbH (Morinaga Milk Industry Co. Ltd.), Mp Biomedicals LLC (Valiant Co. Ltd.), Saputo Inc., Synlait Milk Limited, Tatura Milk Industries Ltd. and Westland Milk Products.

Key Questions Answered in This Report:

• How has the global lactoferrin market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global lactoferrin market?
• What are the key regional markets?
• What is the breakup of the market based on the function?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global lactoferrin market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Lactoferrin Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Function

• 6.1 Iron Absorption
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Anti-Inflammatory
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Intestinal Flora Protection
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Antibacterial
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Immune Cell Stimulation
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Antioxidant
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Application

• 7.1 Food and Beverages
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Infant Formula
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Sports and Functional Foods
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Pharmaceuticals
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Personal Care Products
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Bega Cheese Limited
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
  • 13.3.2 Farbest Brands
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Ferrin-Tech LLC
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Fonterra Cooperative Group Ltd.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Glanbia PLC
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Hoogwegt Group B.V.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Ingredia SA
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
  • 13.3.8 Metagenics Inc. (Alticor Inc.)
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
  • 13.3.9 MILEI GmbH (Morinaga Milk Industry Co. Ltd.)
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
  • 13.3.10 Mp Biomedicals LLC (Valiant Co. Ltd.)
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 Saputo Inc.
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
    • 13.3.11.4 SWOT Analysis
  • 13.3.12 Synlait Milk Limited
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
    • 13.3.12.3 Financials
  • 13.3.13 Tatura Milk Industries Ltd.
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio
  • 13.3.14 Westland Milk Products
    • 13.3.14.1 Company Overview
    • 13.3.14.2 Product Portfolio